XL184

Biotech Gem Exelixis Is Compelling Only for the Long Term
Seeking Alpha
Sat, 08/20/11 - 10:03 pm
Exelixis
cabozantinib
XL184
Promising Data Puts Exelixis Back on Track
Seeking Alpha
Sun, 11/28/10 - 11:30 am
Exelixis
XL184
cancer
Exelixis: Up 32% With Room to Run
Motley Fool
Sat, 11/20/10 - 12:08 pm
XL184
ovarian cancer
prostate cancer
Exelixis
Bristol-Myers Squibb
Exelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184
Yahoo/BusinessWire
Sat, 06/19/10 - 11:19 am
Exelixis
Bristol-Myers Squibb
XL184
investors
Exelixis Presents Positive Data
Yahoo/Zacks
Sat, 05/22/10 - 09:38 am
XL184
Bristol-Myers Squibb
glioblastoma
brain cancer
melanoma
non-small cell lung cancer
small cell lung cancer
hepatocellular carcinoma
pancreatic
gastric
prostate
ovarian
breast cancer